Trademark: 79375534
Word

Status
Pending
Status Code
681
Status Date
Wednesday, September 11, 2024
Serial Number
79375534
Mark Type
2
Filing Date
Thursday, May 18, 2023
Published for Opposition
Tuesday, October 15, 2024

Trademark Owner History

Classifications
5 Pharmaceutical preparations for the central nervous system; pharmaceutical preparations for the treatment of central nervous system (CNS) diseases; pharmaceutical preparations for treating peripheral nervous system disorders; stimulants for the central nervous system; pharmaceutical agents affecting peripheral nervous system; pharmaceutical preparations for the treatment of epilepsy, pharmaceuticals for the treatment of epilepsy and brain health, fever and colds, autoimmune diseases, bacteria-based diseases, bone diseases, cardiovascular and cerebrovascular diseases, central nervous system diseases, diabetes, diseases and disorders of the endocrine system, diseases and disorders of the genitourinary system, diseases and disorders of the musculoskeletal system, eye diseases and conditions, gastrointestinal diseases, gynecological diseases, infectious diseases, inflammatory diseases, insomnia, kidney diseases, metabolic diseases and disorders, neuropathic pain, ocular disorders, pain, respiratory diseases, seizures, sinus congestion, skeletal diseases, skin diseases, and viral diseases, chemico-pharmaceutical preparations for disinfecting and sanitizing, for intimate gynaecological and body hygiene; chemical preparations for pharmaceutical purposes for the treatment of epilepsy and brain health, fever and colds, autoimmune diseases, bacteria-based diseases, bone diseases, cardiovascular and cerebrovascular diseases, central nervous system diseases, diabetes, diseases and disorders of the endocrine system, diseases and disorders of the genitourinary system, diseases and disorders of the musculoskeletal system, eye diseases and conditions, gastrointestinal diseases, gynecological diseases, infectious diseases, inflammatory diseases, insomnia, kidney diseases, metabolic diseases and disorders, neuropathic pain, ocular disorders, pain, respiratory diseases, seizures, sinus congestion, skeletal diseases, skin diseases, and viral diseases; milk ferments for pharmaceutical purposes; decoctions for pharmaceutical purposes for the treatment of epilepsy and brain health, fever and colds, autoimmune diseases, bacteria-based diseases, bone diseases, cardiovascular and cerebrovascular diseases, central nervous system diseases, diabetes, diseases and disorders of the endocrine system, diseases and disorders of the genitourinary system, diseases and disorders of the musculoskeletal system, eye diseases and conditions, gastrointestinal diseases, gynecological diseases, infectious diseases, inflammatory diseases, insomnia, kidney diseases, metabolic diseases and disorders, neuropathic pain, ocular disorders, pain, respiratory diseases, seizures, sinus congestion, skeletal diseases, skin diseases, and viral diseases; digestives for pharmaceutical purposes; ferments for pharmaceutical purposes; lotions for pharmaceutical purposes for the treatment of epilepsy and brain health, fever and colds, autoimmune diseases, bacteria-based diseases, bone diseases, cardiovascular and cerebrovascular diseases, central nervous system diseases, diabetes, diseases and disorders of the endocrine system, diseases and disorders of the genitourinary system, diseases and disorders of the musculoskeletal system, eye diseases and conditions, gastrointestinal diseases, gynecological diseases, infectious diseases, inflammatory diseases, insomnia, kidney diseases, metabolic diseases and disorders, neuropathic pain, ocular disorders, pain, respiratory diseases, seizures, sinus congestion, skeletal diseases, skin diseases, and viral diseases; pastilles for pharmaceutical purposes for the treatment of epilepsy and brain health, fever and colds, autoimmune diseases, bacteria-based diseases, bone diseases, cardiovascular and cerebrovascular diseases, central nervous system diseases, diabetes, diseases and disorders of the endocrine system, diseases and disorders of the genitourinary system, diseases and disorders of the musculoskeletal system, eye diseases and conditions, gastrointestinal diseases, gynecological diseases, infectious diseases, inflammatory diseases, insomnia, kidney diseases, metabolic diseases and disorders, neuropathic pain, ocular disorders, pain, respiratory diseases, seizures, sinus congestion, skeletal diseases, skin diseases, and viral diseases; propolis for pharmaceutical purposes for the treatment of throat and oral cavity conditions; syrups for pharmaceutical purposes for the treatment of epilepsy and brain health, fever and colds, autoimmune diseases, bacteria-based diseases, bone diseases, cardiovascular and cerebrovascular diseases, central nervous system diseases, diabetes, diseases and disorders of the endocrine system, diseases and disorders of the genitourinary system, diseases and disorders of the musculoskeletal system, eye diseases and conditions, gastrointestinal diseases, gynecological diseases, infectious diseases, inflammatory diseases, insomnia, kidney diseases, metabolic diseases and disorders, neuropathic pain, ocular disorders, pain, respiratory diseases, seizures, sinus congestion, skeletal diseases, skin diseases, and viral diseases; ointments for pharmaceutical purposes for the treatment of epilepsy and brain health, fever and colds, autoimmune diseases, bacteria-based diseases, bone diseases, cardiovascular and cerebrovascular diseases, central nervous system diseases, diabetes, diseases and disorders of the endocrine system, diseases and disorders of the genitourinary system, diseases and disorders of the musculoskeletal system, eye diseases and conditions, gastrointestinal diseases, gynecological diseases, infectious diseases, inflammatory diseases, insomnia, kidney diseases, metabolic diseases and disorders, neuropathic pain, ocular disorders, pain, respiratory diseases, seizures, sinus congestion, skeletal diseases, skin diseases, and viral diseases; pharmaceutical preparations for skin care; vitamin supplement patches; dietary supplements with a cosmetic effect; royal jelly dietary supplements; pollen dietary supplements; propolis dietary supplements; nutritional supplements; dietetic foods adapted for medical purposes; analgesics; anaesthetics; antibiotics; anti-inflammatories; antioxidant pills being food supplements; antiseptics; balms for medical purposes; medicated sweets; collyrium; cachets for pharmaceutical purposes for the treatment of epilepsy and brain health, fever and colds, autoimmune diseases, bacteria-based diseases, bone diseases, cardiovascular and cerebrovascular diseases, central nervous system diseases, diabetes, diseases and disorders of the endocrine system, diseases and disorders of the genitourinary system, diseases and disorders of the musculoskeletal system, eye diseases and conditions, gastrointestinal diseases, gynecological diseases, infectious diseases, inflammatory diseases, insomnia, kidney diseases, metabolic diseases and disorders, neuropathic pain, ocular disorders, pain, respiratory diseases, seizures, sinus congestion, skeletal diseases, skin diseases, and viral diseases; adhesive plasters for medical purposes; medicated toothpaste, mineral dietary supplements; medicines for human purposes for the treatment of epilepsy and brain health, fever and colds, autoimmune diseases, bacteria-based diseases, bone diseases, cardiovascular and cerebrovascular diseases, central nervous system diseases, diabetes, diseases and disorders of the endocrine system, diseases and disorders of the genitourinary system, diseases and disorders of the musculoskeletal system, eye diseases and conditions, gastrointestinal diseases, gynecological diseases, infectious diseases, inflammatory diseases, insomnia, kidney diseases, metabolic diseases and disorders, neuropathic pain, ocular disorders, pain, respiratory diseases, seizures, sinus congestion, skeletal diseases, skin diseases, and viral diseases; medicines for dental purposes; medicines for veterinary purposes for the treatment of epilepsy and brain health, autoimmune diseases, bacteria-based diseases, bone diseases, cardiovascular and cerebrovascular diseases, central nervous system diseases, diabetes, diseases and disorders of the endocrine system, diseases and disorders of the genitourinary system, diseases and disorders of the musculoskeletal system, eye diseases and conditions, gastrointestinal diseases, infectious diseases, inflammatory diseases, kidney diseases, metabolic diseases and disorders, neuropathic pain, ocular disorders, pain, respiratory diseases, seizures, skeletal diseases, skin diseases, and viral diseases; chemical preparations for medical purposes for the treatment of epilepsy and brain health, fever and colds, autoimmune diseases, bacteria-based diseases, bone diseases, cardiovascular and cerebrovascular diseases, central nervous system diseases, diabetes, diseases and disorders of the endocrine system, diseases and disorders of the genitourinary system, diseases and disorders of the musculoskeletal system, eye diseases and conditions, gastrointestinal diseases, gynecological diseases, infectious diseases, inflammatory diseases, insomnia, kidney diseases, metabolic diseases and disorders, neuropathic pain, ocular disorders, pain, respiratory diseases, seizures, sinus congestion, skeletal diseases, skin diseases, and viral diseases; chemical preparations for veterinary purposes for the treatment of epilepsy and brain health, autoimmune diseases, bacteria-based diseases, bone diseases, cardiovascular and cerebrovascular diseases, central nervous system diseases, diabetes, diseases and disorders of the endocrine system, diseases and disorders of the genitourinary system, diseases and disorders of the musculoskeletal system, eye diseases and conditions, gastrointestinal diseases, infectious diseases, inflammatory diseases, kidney diseases, metabolic diseases and disorders, neuropathic pain, ocular disorders, pain, respiratory diseases, seizures, skeletal diseases, skin diseases, and viral diseases; nutraceutical preparations for therapeutic or medical purposes for the treatment of epilepsy and brain health, autoimmune diseases, bacteria-based diseases, bone diseases, cardiovascular and cerebrovascular diseases, central nervous system diseases, diabetes, diseases and disorders of the endocrine system, diseases and disorders of the genitourinary system, diseases and disorders of the musculoskeletal system, eye diseases and conditions, gastrointestinal diseases, infectious diseases, inflammatory diseases, kidney diseases, metabolic diseases and disorders, neuropathic pain, ocular disorders, pain, respiratory diseases, seizures, skeletal diseases, skin diseases, and viral diseases; pharmaceutical preparations for the treatment of epilepsy and brain health, autoimmune diseases, bacteria-based diseases, bone diseases, cardiovascular and cerebrovascular diseases, central nervous system diseases, diabetes, diseases and disorders of the endocrine system, diseases and disorders of the genitourinary system, diseases and disorders of the musculoskeletal system, eye diseases and conditions, gastrointestinal diseases, infectious diseases, inflammatory diseases, kidney diseases, metabolic diseases and disorders, neuropathic pain, ocular disorders, pain, respiratory diseases, seizures, skeletal diseases, skin diseases, and viral diseases; mouthwashes for medical purposes; veterinary preparations, namely, veterinary vaccines; purgatives; dietetic substances in the nature of foods, capsules, confectionery, beverages, infusions, syrups, tablets adapted for medical use; suppositories being pharmaceutical preparations for the prevention and/or treatment of epilepsy and brain health, autoimmune diseases, bacteria-based diseases, bone diseases, cardiovascular and cerebrovascular diseases, central nervous system diseases, diabetes, diseases and disorders of the endocrine system, diseases and disorders of the genitourinary system, diseases and disorders of the musculoskeletal system, eye diseases and conditions, gastrointestinal diseases, infectious diseases, inflammatory diseases, kidney diseases, metabolic diseases and disorders, neuropathic pain, ocular disorders, pain, respiratory diseases, seizures, skeletal diseases, skin diseases, and viral diseases; herbal teas for medicinal purposes
The mark consists of a shaded rectangle with two partial curved bands. One appears on the top right of the mark and the other appears on the bottom left.

Trademark Events
Aug 8, 2023
Application Filing Receipt Mailed
Aug 3, 2023
Sn Assigned For Sect 66a Appl From Ib
Aug 4, 2023
New Application Office Supplied Data Entered
Feb 12, 2024
Assigned To Examiner
Feb 20, 2024
Non-Final Action Written
Feb 21, 2024
Non-Final Action (Ib Refusal) Prepared For Review
Mar 13, 2024
Refusal Processed By Mpu
Mar 13, 2024
Non-Final Action Mailed - Refusal Sent To Ib
Sep 6, 2024
Correspondence Received In Law Office
Sep 6, 2024
Teas/Email Correspondence Entered
Sep 6, 2024
Teas Response To Office Action Received
Sep 6, 2024
Teas Change Of Correspondence Received
Sep 6, 2024
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Sep 6, 2024
Teas Change Of Owner Address Received
Sep 6, 2024
Applicant/Correspondence Changes (Non-Responsive) Entered
Sep 6, 2024
Attorney/Dom.Rep.Revoked And/Or Appointed
Sep 6, 2024
Teas Change Of Domestic Representatives Address
Sep 10, 2024
Approved For Pub - Principal Register
Apr 2, 2024
Refusal Processed By Ib

Trademark Alertz updated from USPTO on 2030-01-24